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Abstract
Cell fusion between circulating bone marrow-derived cells (BMDCs) and non-hematopoietic cells is well documented in
various tissues and has recently been suggested to occur in response to injury. Here we illustrate that inflammation within
the intestine enhanced the level of BMDC fusion with intestinal progenitors. To identify important microenvironmental
factors mediating intestinal epithelial cell fusion, we performed bone marrow transplantation into mouse models of
inflammation and stimulated epithelial proliferation. Interestingly, in a non-injury model or in instances where inflammation
was suppressed, an appreciable baseline level of fusion persisted. This suggests that additional mediators of cell fusion exist.
A rigorous temporal analysis of early post-transplantation cellular dynamics revealed that GFP-expressing donor cells first
trafficked to the intestine coincident with a striking increase in epithelial proliferation, advocating for a required fusogenic
state of the host partner. Directly supporting this hypothesis, induction of augmented epithelial proliferation resulted in a
significant increase in intestinal cell fusion. Here we report that intestinal inflammation and epithelial proliferation act
together to promote cell fusion. While the physiologic impact of cell fusion is not yet known, the increased incidence in an
inflammatory and proliferative microenvironment suggests a potential role for cell fusion in mediating the progression of
intestinal inflammatory diseases and cancer.
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Introduction
Cell fusion between bone marrow-derived cells (BMDCs) and
somatic cells has been reported in a number of different organ
systems as an intriguing means for tissue regeneration in response to
injury [1–10]. The low incidence described in early studies led
critics to suggest that cell fusion was physiologically inconsequential.
However, two groups recently published that chronic inflammation
can potentiate this process in the brain, muscle, liver and heart
[11,12] suggesting that physiologic mediators can affect cell fusion.
We have previously reported that BMDCs fuse with intestinal stem
or progenitor cells after c-IR-induced epithelial injury and that cell
fusion is markedly increased in intestinal tumors [8]. Intestinal
tumors are well-characterized by chronic inflammation [13–16]
leading to the possibility that inflammation plays an important role
in tumor progression. Notably, patients with chronic intestinal
inflammation have a higher incidence for developing colorectal
cancer [17,18]. This highlights the importance of understanding
how the microenvironment impacts cell fusion and if this process
contributes to tumorigenesis.
Results and Discussion
To identify if well-characterized tumor microenvironmental
factors mediate intestinal cell fusion, we set out to directly test the
hypothesis that cell fusion is enhanced by inflammation. Utilizing
the established mouse model of colonic inflammation, the
IL-10
2/2 mouse [19–21], we compared the incidence of epithelial
cell fusion in mice transplanted with green fluorescent protein
(GFP)-expressing whole bone marrow (WBM) with those treated
with the anti-inflammatory drug, 5-aminosalicylic acid (5-ASA), or
to wild-type (WT) transplanted mice (Figure 1A). Analyses of
peripheral blood after WBM transplantation revealed high levels
of donor-blood reconstitution in all analyzed mice (.90% GFP
expression, data not shown). Cell fusion between donor BMDCs
and the colonic epithelium was identified by co-expression of both
the donor marker, GFP, and the WT epithelial marker, b-
galactosidase (b-gal) by confocal microscopy (Figure 1C–E). GFP
epithelial expression was detected by immunohistochemical
analysis using antibodies to GFP or by direct fluorescence (Figure
S1A–F). Proper controls were analyzed to confirm that epithelial
GFP-expression was not due to artifact (Figure S2). GFP-
expressing cells residing in the epithelial compartment were
confirmed to be predominantly epithelial cells based upon
morphology and co-expression of E-cadherin (Figure S1G–J).
Phenotypically distinct CD45-positive cells (intra-epithelial lym-
phocytes) were also present in this compartment, but were much
smaller and did not extend to the apical border (Figure S1K–O).
Together, these rigorous standards definitively establish that
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can be accurately identified.
Cell fusion was analyzed in the chronically inflamed colon from
male IL-10
2/2 mice that were transplanted with GFP-expressing
WBM from a female donor. Detection of the recipient marker
(Y-chromosome) by in situ hybridization and the donor marker
(GFP) by immunohistochemical analysis provides an additional
approach to analyze cell fusion (Figure 1F-I). The presence of co-
localized Y-chromosome in GFP-expressing cell regions (Figure 1I)
indicates that cell fusion occured in the presence of chronic
inflammation. Controls verifying the specificity of the Y-chromo-
some probe are presented in Figure S3.
We chose to use epithelial GFP-expression as the basis for
quantifying cell fusion based upon two criteria. First, cell fusion
was initially confirmed in all experimental groups and in all
recipient backgrounds used in the studies reported here. This was
established using confocal microscopy and immunohistochemical,
or histochemical co-detection of donor and recipient markers in
the same epithelial cell (Figure 1C-I and Figure S4A–C). Second,
we and others have reported that in all of the mice surveyed for
cell fusion, the donor marker predominatly expresses the recipient
marker [1,7,8,11,12,22], or in other words, presence of the donor
marker in the intestinal epithelium does not support transdiffer-
entiation, a change in cell fates from the BMDC to a non-
hematopoietic cell type. Based upon these criteria, cell fusion was
quantified in each animal by counting the percentage of crypt
units (crypt/villus or crypt/cuff in the small intestine or colon,
respectively) that contained GFP-expressing epithelial cells in a
total of 1500 crypt units.
Interestingly, we observed a dramatically higher amount of
epithelial cell fusion in WBM-transplanted WT mice than what we
had previously reported [8]. This observation is the result of
optimization of our transplantation protocols for intestinal cell
fusion, including the use of a more robust and detectable GFP-
expressing transgenic line for donor bone marrow (Osb-Y01)
[23,24], more effective GFP detection by antibody staining, and
establishing stringent quantification methods. We now report that
fusion within the intestinal epithelium is detected at a level of
37.363.6% in the distal small intestine (DSI; n=10, Figure S4D)
and 20.662.1% (n=4) in the colon. The prominent level of cell
fusion sets the intestine apart from other systems where only low
levels are observed [1–7,9,10], suggesting that there is a
physiologically important role for cell fusion in self-renewing tissues.
In assessing the role of inflammation, direct comparison of cell
fusion in colons from IL-10
2/2 mice (chronic inflammation) with
WT controls revealed a significant increase (IL-10
2/2:3 5 . 2 69.6%,
n=3; WT: 19.0461.1%, n=9; P=0.013) (Figure 1B). To further
implicate the presence of local intestinal inflammation in promoting
cell fusion, we treated IL-10
2/2 mice with the anti-inflammatory
drug, 5-ASA [25], a standard therapy for inflammatory bowel disease
in humans. Treatment with 5-ASA resulted in a marked decrease
in cell fusion (8.562.7%, n=3; Figure 1B) compared to untreated
IL-10
2/2 mice. This dramatic effect of modulating microenviron-
mental inflammation on cell fusion is depicted in tissue sections from
each of the experimental groups and presented in Figure S5. We
confirmed by quantitative reverse transcriptase-polymerase chain
reaction (qRT-PCR) that IL-10
2/2 intestines had heightened
inflammation and that treatment with 5-ASA greatly suppressed
the inflammatory response [26,27]; (Mchr1, Melanin-concentrating
hormone receptor1 and IL-1b,I n t e r l e u k i n - 1 b, Table S1).
It is well-established that c-IR also induces an inflammatory
response in the intestine [28]. Given that the transplantation
procedure involved c-IR, we utilized a parabiosis approach to
introduce traceable bone marrow without c-IR. Surgically joined
parabiotic mouse pairs were maintained together for 4–6 weeks to
establish a shared circulating blood supply [29–31], which was
confirmed by flow cytometry (data not shown). After the mice were
separated, intestinal inflammation was induced by administration
of dextran sodium sulfate (DSS), a well-documented protocol for
Figure 1. Inflammation promotes cell fusion between bone
marrow-derived cells (BMDCs) and intestinal epithelium. (A)
Schematic representation of experimental design. Whole bone marrow
(WBM) from a female GFP-expressing donor mouse was transplanted
into lethally irradiated wild-type (WT) or IL-10
2/2 male mice. A subset of
IL-10
2/2 recipient mice were given the anti-inflammatory drug, 5-ASA.
(B) Comparison of cell fusion in colonic epithelium between recipient
mice. Cell fusion is quantified as the percentage of crypt/cuff units with
at least one GFP-expressing cell. (C–E) Single plane confocal image of a
colon cross-section from a ROSA mouse transplanted with GFP WBM.
GFP expression (C, green) and b-gal expression (D, red) exist in the same
cell (E, yellow) indicating fusion between the donor and recipient cell.
Arrowheads denote fused epithelium on the cuff and in the crypts. (F–I)
GFP-expressing epithelial cells in transplanted IL-10
2/2 colons are also
fusion products, as determined by co-expression of GFP (F, brown, right
box) and the Y chromosome (G, red, right box). (H & I) Higher
magnification of GFP-negative and GFP-positive boxed regions from
panels F & G. Y chromosome is found in Hoechst stained nuclei (blue,
examples circled in white). Solid white line denotes epithelial/luminal
border; dashed white lines indicate epithelial/mesenchymal border.
Bars=25 mm.
doi:10.1371/journal.pone.0006530.g001
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(Figure 2A). The DSS phenotype can be appreciated on both gross
morphologic and cellular levels (WT compared to DSS-treated,
Figure S6). Again, cell fusion was apparent in the DSS-induced
colons of these animals by co-detection of donor and recipient
markers using confocal microscopy (b-gal and GFP; Figure 2B–D).
Distinct epithelial regions expressing both GFP and b-gal were
readily detectible in both the crypt cuff (Figure 2B,C; arrowheads)
and in the colonic crypt (Figure 2 B,D; arrowheads). Quantifica-
tion of cell fusion revealed a statistically significant increase in the
DSS-treated parabiotic partners compared to untreated controls
(Figure 2E; WT: 5.863.4%, n=5; DSS-treated: 19.662.6%,
n=4; P=0.017). These data, along with our observations in the
WBM-transplanted mice strongly implicate inflammation as a key
mediator for pathologically-induced cell fusion in the intestine.
In support of a physiologic role for intestinal epithelial cell
fusion, an appreciable baseline level of cell fusion was observed in
non-DSS treated parabiotic pairs in both the colon (-DSS,
5.863.4%, n=5) and DSI (-DSS, 15.063.2%, n=5) (Figure 2E).
Even though parabiosis surgery is well-accepted as a ‘‘non-
damage’’ model, there is considerable post-surgery stress to the
animal resulting in weight loss, and it is possible that intestinal
injury occurs during or immediately after the surgical procedure.
To rule out the possibility of surgically-induced inflammation that
could potentially create an artificial baseline level of cell fusion
within the intestinal epithelium, we repeated the parabiotic
experiment by joining GFP and ROSA mice along with oral
administration of an anti-inflammatory drug cocktail during and
after the surgery (Figure 2A). In these animals, the baseline level of
cell fusion persisted and was unchanged relative to the untreated
animals in both the colon (5-ASA treated: 5.362.0%, n=5,
P=0.895) and DSI (5-ASA treated: 21.367.8%, n=5,P=0.477)
(Figure 2E). Further, we confirmed by qRT-PCR that animals
receiving an anti-inflammatory drug regimen had minimal
Figure 2. Intestinal cell fusion persists at low levels in a non-damage model system. (A) Schematic representation of parabiosis
experimental design. GFP and ROSA mice were surgically joined. (B–E) Extensive cell fusion was observed in colons from DSS-treated animals. (B)
Single plane confocal microscopy images of GFP (green) and b-galactosidase (red) detected by antibodies demonstrate fusion by co-localization in
yellow. Arrowheads denote fused cells. (C & D) depict higher magnifications of the boxed regions in panel B. Nuclei were visualized with the Hoechst
dye (blue). Bars=25 mm. (E) Cell fusion in DSS-treated animals was significantly increased over non-treated animals (P=0.017). When the animals
were given 5-ASA during parabiosis to inhibit inflammation, there was no difference in fusion levels in colon (blue bars; P=0.895) or DSI (green bars;
P=0.477), however, a baseline level of fusion existed in both tissues.
doi:10.1371/journal.pone.0006530.g002
Intestinal Cell Fusion
PLoS ONE | www.plosone.org 3 August 2009 | Volume 4 | Issue 8 | e6530epithelial inflammation (Table S1). This is in agreement with the
data presented in Figure 1B, which showed IL-10
2/2 mice treated
with 5-ASA after transplantation also displayed appreciable levels
of cell fusion. Together, these observations highlight the existence
of an endogenous baseline level of epithelial cell fusion in the
intestine, suggesting that the nature of rapidly self-renewing
epithelium may sensitize or prime it for fusion with circulating
BMDCs under certain microenvironmental conditions. These
findings strongly suggest that additional factors are important for
the fusion process in the intestine.
Currently, reports in other organ systems show that baseline
levels of cell fusion are relatively non-detectable [11,12,33].
Important differences between these other organ systems and the
intestine is that the intestinal epithelium is a rapidly renewing,
highly proliferative tissue that dynamically responds to its
microenvironment. An additional distinction between the intestine
and the other somatic organs lies in the host fusogenic cell. We
have previously reported that BMDC fusion occurs with a stem or
progenitor population in the intestine [8], whereas in other tissues
fusion takes place with differentiated cells [1,7,12,22]. These
differences along with the respective disparity in homeostatic cell
fusion levels suggest that host-cell proliferative status may be a
factor in the fusion process. It is well established that c-IR elicits
intestinal microenvironmental inflammation [28], and that the
epithelium undergoes massive apoptosis that peaks within the first
24 h post-irradiation [34] accompanied by a proliferative response
[35]. Further, we have previously shown that c-IR also stimulates
the Wnt signaling pathway, a critical regulator of intestinal
epithelial proliferation [36]. Taken along with our observation that
fusion is increased in a tumor setting [8], these elements implicate
cell death or proliferation signals as possible additional factors that
promote cell fusion.
To gain additional insights from the pre-fusion intestinal
microenvironment, we detailed the temporal events surrounding
the generation of cell fusion hybrids. The dynamic trafficking of
GFP-expressing BMDCs to the intestine was defined at various
early time points post-transplantation. Since our initial observa-
tions implicated progenitor cells as the host fusion partner [8], we
focused our analyses on the stem cell niche. At 1 day post-
transplant, the first detectable GFP-positive BMDCs were present
scattered around the crypt region in the intestinal mesenchymal
compartment (Figure 3A, B; arrowheads). By 4 days post-
transplant, an appreciable level of GFP-expressing BMDCs
populated the intestine, but GFP-expressing epithelium was not
yet observed (Figure 3E, F; arrowheads). Cell fusion in the
epithelial compartment (Figure 3J; yellow brackets and arrow-
heads) was routinely detected 7 days post-transplant and was
accompanied by high levels of GFP-expressing cells in the
mesenchyme (Figure 3I,J; red arrowheads). The arrival of GFP-
expressing BMDCs into the intestine coincided with a striking
increase in proliferation of the intestinal epithelium, appreciated
both histologically by Hematoxylin and Eosin (H&E) staining and
by Ki67 antibody staining (Figure 3C,D,G,H,K,L; yellow
brackets). Intriguingly, the dramatic proliferative epithelial re-
sponse coincident with clustering of GFP-expressing BMDCs in
the stem cell niche suggested that intestinal cell fusion may also be
governed by the proliferative status of the recipient cell.
Thehomeostatic,orbaseline,levelsofcellfusionobservedinboth
transplanted mice with suppressed inflammation and parabiotic
mice may be due to the intrinsic proliferative nature of the intestinal
crypt. Approximately 60% of crypt cells are actively engaged in the
cell cycle [35,37] supporting rapid self-renewal of the epithelium.
We and others [35] have shown that this proliferative zone is
expanded in response to c-IR (Figure 3G,H). However, in other
tissues where cell fusion occurs after c-IR, it is reported that the host
fusion partner is a differentiated cell type that is not known to be
actively cycling [1,11,22]. Despite this, notexin-induced injury in
skeletalmuscle,whereBMDCfusion has been described,results ina
transient increase in cell numbers [38], suggesting that these
differentiated cells might be capable of entering the cell cycle. Based
uponthis observation and our data in the intestine, we hypothesized
that host cell proliferative status is important in driving cell fusion.
Therefore, to determine if entry into the cell cycle might also be
stimulated in a subset of other organs after c-IR, we surveyed for
cycling cellsintheliverandskeletalmuscleusingantibodiestoKi67.
A visible increase of Ki67-positive cells was observed (Figure S7),
further supporting the idea that cell cycle status of the host cell
within these organs may also mediate cell fusion.
Therefore, to directly implicate epithelial proliferative status as a
contributing host factor in promoting cell fusion, we utilized a
mouse model in which we could temporally manipulate epithelial
proliferation in the intestine. The previously described intestinal-
specific, inducible AhCre mouse [39] harboring floxed Apc alleles
[40], results in a dramatic induction of intestinal epithelial
proliferation upon Cre activation [41] and Figure 4C,E. We
showed by H&E that an increase in immune infiltrate was not
readily apparent during the timeframe in which epithelial
proliferation was stimulated (compare Figure 4B,C). Further,
qRT-PCR showed that there was not an increase in inflammation
in these mice (Table S1). To evaluate cell fusion in this
proliferative model, we transplanted AhCre
+;Apc
fl/fl mice on day
0, induced epithelial proliferation on day 2, then analyzed cell
fusion in the intestine on day 7 (Figure 4A). Dramatically, a
significant increase in epithelial cell fusion within the crypt and
villus, compared to mock-injected controls, was observed
(Figure 4F–K). Cell fusion in crypt/villus units displayed three
distinct patterns: fusion restricted to the crypts, fusion on the villus
only, and fusion in both crypt and villus epithelium (Figure 4G–J).
Differences in each of these three patterns were significant when
compared to mock-injected control intestines (crypt: P=0.056;
villus: P=0.011; crypt/villus: P=0.009; mock injected n=5,
AhCre
+;Apc
2/2 n=7). Because the induction of proliferation occurs
over a window of 4 days, the differences in the crypt, villus or
crypt/villus fusion expression patterns likely represented different
kinetics of cell fusion and subsequent expansion of progeny. For
example, it is possible that fusion in the crypt epithelium represents
an initial fusion event in a proliferative cell that occurred only a
short time before analysis (perhaps on day 5–6). Likewise, GFP-
expressing epithelia in both the crypt and villus might represent an
early fusion event in a crypt-based progenitor cell, perhaps on day
2. Notably, crypt-based differentiated Paneth cells which have a
.20 day turnover [42], remain unmarked and are not descendents
from the cell fusion event (Figure 4J).
Importantly, detection of cell fusion only on the villus where
proliferative cells do not normally reside, strongly implicated the
proliferative status of the host cell as a critical component of cell
fusion. Noticeably, each crypt/villus unit had extensive GFP-
expressing cells which could argue for a more rapid expansion of
progeny from the original fusion event. However, the fact that
there were significantly more total crypt/villus units harboring at
least one GFP-expressing cell indicated there were also more initial
cell fusion events (P=0.009). Our assay cannot distinguish
between whether the host fusion target is a progenitor or if it is
a cell actively engaged in the cell cycle. Regardless, our data
indicates that the host cell must be receptive or primed for the
fusion process. Importantly, these observations suggest that
proliferative capacity of the host cell contributes to promote cell
fusion in the intestinal epithelium.
Intestinal Cell Fusion
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is if the generated cell fusion hybrids have a physiologic impact on
normal organ function. Although it is apparent that these intestinal
cell fusion hybrids retain an overt epithelial phenotype, it is
unclear if the BMDC transcriptome is modified. To explore the
possibility that cell fusion results in nuclear reprogramming of the
donor genome, we transplanted WBM from mice harboring a
Villin-Cre transgene [43] into recipient mice homozygous for the
floxed Apc allele [40](Figure 5A). Villin is an epithelial-specific
promoter and Cre recombinase is not expressed in any of the
blood lineages under this context [43]. Therefore, functional Cre
recombination of the Apc allele would only occur if Cre
recombinase were activated, such as in the event of cell fusion
between the BMDC (Villin-Cre) and the epithelial cell. The
intestines from transplanted mice possessed hyperproliferative
epithelial regions in both the distal small intestine and colon
appreciated by wholemount analysis (Figure 5B,D) and morpho-
logically by H&E (Figure 5C,E). The polyp-like region in the distal
small intestine was reminiscent of Min mouse polyps [44] where
the Apc allele is mutated. To confirm the phenotype was due to
Cre mediated recombination of the Apc allele, we isolated DNA
from intestinal tissue sections and performed PCR with primers
specific to the recombined floxed Apc allele. In both the DSI and
the colon, a 258 bp amplicon was identified, confirming that Cre
recombinase had been activated within the tissue. This observa-
tion not only strongly supports the occurrence of cell fusion, but it
Figure 3. Increased epithelial proliferation occurred after gamma-irradiation. Wild-type (WT) mice were transplanted with GFP-expressing
whole bone marrow (WBM). The distal small intestine was analyzed at 24 h increments for 1 week. (A–B) At 1 day post-transplantation, few GFP-
positive cells (green) were located in the mesenchyme (arrowheads) and none were found in the epithelium. (C–D) H&E and Ki67 detection (red) with
Hoechst dye (blue) indicated normal morphology at one day post-transplant. (E–F) At 4 days post-transplant, more GFP-positive cells were found
surrounding the crypt (arrowheads), while none were detected in the epithelium. (G–H) H&E and Ki67 staining (red) revealed a dramatic increase in
proliferation of the crypts. (I–J) By 7 days post-transplant, single plane confocal microscopy depicts the presence of GFP-positive cells in the
mesenchyme surrounding the crypt as well as in the villi core (red arrowheads). GFP-positive epithelium was observed in the stem cell (yellow
arrowheads) and transient-amplifying (yellow bracket) zones of crypts. Epithelial cells are marked with antibodies against E-cadherin (red). (K–L) H&E
and Ki67 staining depicted morphology close to normal by 7 days post-transplant. Dashed white lines indicate epithelial/mesenchymal border. Red
boxes in (A,E,I) are displayed in higher magnification in (B,F,J). Yellow brackets denote the depth of the Ki67-positive cells in (C,G,K). The nuclear dye
Hoechst is depicted in grayscale in (A,E,I) and in blues in (D,H,L). D & H are the same tissue sections as A & E, respectively. Bars=25 mm.
doi:10.1371/journal.pone.0006530.g003
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BMDC gene expression by activating an epithelial-specific
promoter. While this functional evidence supports the implication
that cell fusion can create a genetically distinct hybrid cell, the
extent of reprogramming of the genome remains an intriguing and
important future focus of investigation.
It is clear, from our studies presented here and previous reports
[8,11,12,22] that cell fusion between BMDCs and non-hemato-
Figure 4. Increased epithelial proliferation correlates with increased cell fusion. (A) Schematic representation of experimental design.
AhCre
+;Apc
fl/fl mice were transplanted with GFP-expressing whole bone marrow (WBM) on day 0. Two days later, Cre recombinase was induced by b-
naphthoflavone (b-NF) administration for 4 consecutive days (days 2–5). Mice were sacrificed on day 7 and the distal small intestine analyzed for
fusion (B–E). The intestinal-specific deletion of Apc resulted in an extensive hyperproliferation of crypt cells compared to wild-type (WT) mice, as seen
by H&E stain (C vs. B) and Ki67 staining (red, indicated by yellow brackets; E vs. D). (F–K) Detection of GFP-expressing cells (green; yellow arrowheads
mark examples) denoting cell fusion was increased in the AhCre
+;Apc
2/2 mice compared to mock-injected WT mice. Three patterns of cell fusion were
observed: (G) crypt-only, (H) villus-only, (I) both crypt and villus regions in one crypt/villus unit. Panel (J) is a higher magnification of the red box in
panel (I) demonstrating that the Paneth cell region at the base of the crypt remained GFP-negative. Solid white lines denote epithelial/luminal border;
dashed white lines indicate epithelial/mesenchymal border. Bars=25 mm. (K) A significant increase in fusion was observed in villus only (P=0.011)
and crypt/villus (P=0.009) AhCre
+;Apc
2/2 mice (gray bars) compared to mock-injected WT mice (black bars).
doi:10.1371/journal.pone.0006530.g004
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we report considerable baseline levels of cell fusion in the intestine
under homeostatic conditions, greater than that reported in other
organ systems [1,11,22]. Further, we demonstrate that intestinal
cell fusion with BMDCs is mediated by both inflammation and
cellular proliferation. A possible physiologic role for intestinal cell
fusion may be to facilitate rapid regeneration of the epithelial
barrier after injury. Because the intestinal epithelium is the largest
surface barrier to the external environment, barrier maintenace is
critical for the organism’s survival. If cell fusion participates in this
rapid response, the intestine is certainly poised to solicit fusion with
both its intrinsic immune capacity and functional proliferation.
While previous reports dismiss the importance of cell fusion or tie
its potential to therapeutic gene replacement strategies, our data
implicates cell fusion in a role to potentially impact inflammatory
disease pathogenesis, including inflammatory bowel disease and
cancer. Only by understanding the long-term fate of the epithelial
cell fusion hybrid will we uncover its physiologic potential in both
homeostasis and disease.
Materials and Methods
Ethics Statement
Mice were housed in a specific pathogen-free environment
under strictly controlled light cycle conditions, fed a standard
rodent Lab Chow (#5001 PMI Nutrition International), and
provided water ad libitum. All procedures were approved and
performed in accordance with the Oregon Heatlth and Science
University animal ethics committee: the Oregon Health & Science
University Institutional Animal Care and Use Committee. There
are no human subjects involved in this study.
Mice
The C57Bl/6, 129/Sv or ROSA [45] (WT), IL-10
2/2 [19,20]
and Villin-Cre [43] mice were obtained from The Jackson
Laboratory. AhCre mice[39] were kindly provided by Dr. Douglas
Winton (University of Cambridge). Osb-Y01 (GFP) [23,24] and
Apc
580S mice (designated as Apc
fl/fl in the unrecombined state and
Apc
2/2 after recombination) [40] were bred in-house.
Bone Marrow Transplantation
Whole bone marrow (WBM) transplantation was carried out as
we have previously described with some modifications [8]. Briefly,
6-week-old recipient male WT, IL-10
2/2, Apc
fl/fl,o rAhCre
+;Apc
fl/fl
mice received whole-body c-IR (12 Gy: in two 6 Gy doses, 4 hours
apart). BMDCs were harvested from 5- to 12-week-old donor GFP
[23,24] or Villin-Cre [43] mice using standard procedures [46],
filtered to obtain a single-cell suspension and resuspended in Hank’s
balanced salt solution supplemented with 3% fetal bovine serum
and 10 mM HEPES. A total of 1610
7 WBM cells were then
injected retro-orbitally into recipient mice. To confirm hematopoi-
etic engraftment, peripheral blood leukocytes were isolated from
recipient mice as previously reported [47] and analyzed using a
Becton Dickinson FACSCalibur.
Parabiosis
Parabiosis surgery was performed between GFP and ROSA
mice (n=5 pair for WT, n=5 pair for 5-ASA, n=4 pair for DSS
treatments) as described previously [47]. Briefly, pairs of 6- to 12-
week age- and weight-matched mice were surgically joined from
the elbow to knee. Each parabiotic partner was given recombinant
human granulocyte colony-stimulating factor (250 mg/kg subcu-
taneously; Amgen) for 4 days starting at day 17 post-surgery [29].
Mice were separated approximately 7 weeks after surgery and
intestinal tissue analyzed.
Manipulation of intestinal inflammation
To suppress inflammation in IL-10
2/2 mice, 5-aminosalicylic
acid (5-ASA) was administered in the drinking water at the time of
WBM transplantation (500 ppm 5-ASA/5mM Sodium Phos-
phate; Sigma). Mice were analyzed 3–7 months later. For
parabiosis studies, animals were administered 5-ASA 1 week prior
to surgery and continually until surgical separation. Meloxicam (a
Cox-2 inhibitor; Boehringer Ingelheim) was concurrently admin-
istered for 4 days post-surgery. To induce inflammation in
parabiotic mice, dextran sodium sulfate (DSS; TdB Consultancy
AB) was given in drinking water (2.5% DSS in 5% sucrose) [32] 1
week after separation followed by regular water for 1 week, at
which point the animals were sacrificed and analyzed.
Intestinal proliferative model
To examine enhanced proliferation in the mouse intestine, we
crossed Apc
fl/fl [40] mice to the AhCre intestinal-specific inducible
mouse line [39]. AhCre
+; Apc
fl/fl progeny were induced by
intraperitoneal injection of b-naphthoflavone (b-NF; Sigma)
dissolved in corn oil (80 mg/kg) for four days [41] and analyzed
2 days later. For transplantation studies, b-NF injections were
initiated two days post-transplant.
Figure 5. Bone-marrow/epithelial cell fusion causes genetic
reprogramming. (A) Schematic diagram of transplantation scheme.
Whole bone marrow (WBM) from mice expressing Cre recombinase
driven by the intestinal epithelial-specific Villin promoter (VilCre) was
transplanted into recipient mice that were homozygous for floxed Apc.
Resulting intestinal phenotypes were observed in transplanted mouse
intestine by wholemount analysis as polyps (B) in the distal small
intestine (DSI) and as thickened unorganized epithelia (D) in the colon.
H&E staining confirmed the phenotypic morphology (C,E). Bars in B &
D=1 mm, bars in C & E=25 mm. (F) To confirm that the phenotype was
the result of recombination at the Apc allele, PCR analysis of epithelium
from recipient mice using primers that specifically detect the
recombined Apc allele was performed. The 258 bp band was present
in the transplanted DSI and colon samples, indicating cell fusion by
activation of Cre-recombinase.
doi:10.1371/journal.pone.0006530.g005
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Cell fusion was confirmed by co-localization of GFP expression
developed for brightfield and Y-chromosome fluorescence in situ
hybridization, or for fluorescent detection by confocal microscopy
with co-staining of antibodies for b-gal (1:500, Immunology
Consultants Laboratory, Inc.) and GFP as reported previously [8]
(n=18).
Mice were analyzed at varying times post-transplantation
(IL-10
2/2 studies: 3 and 7 months post-transplant, n=7; pro-
liferation studies: n=13; WT transplants: 1–11 months for colon,
n=9, 3–11 months for DSI, n=10; genetic recombination studies:
2–5 months, n=11). Analysis of parabiotic pairs took place at time
of separation (4–9 weeks; n=10) or 3 weeks after separation for
DSS studies (n=4). Small intestine and colon was isolated en bloc,
processed for wholemount imaging and subsequent frozen block
preparation and sectioned as previously described [48]. Tissue
sections (5 mm) were analyzed for GFP-expressing cells by using
polyclonal antibodies to GFP (1:500; Molecular Probes) and
fluorescent secondary antibodies (1:500, Alexa 488, Molecular
Probes; 1:500, Cy3 and 1:250, Cy5, Jackson Immuno Research) or
for brightfield detection by using biotin–avidin secondary
antibodies and visualization with 3-39-diaminobenzidine (DAB)
according to the manufacturer’s guidelines (Vector Laboratories).
For controls, tissues were stained with anti-CD45 (1:500;
eBioscience), anti-E-cadherin (1:1000; Zymed), and anti-laminin
(1:1000; Chemicon) followed by detection with appropriate
fluorescent secondary antibodies. In some cases, tissue sections
were also labeled with antibodies to the proliferation marker Ki67
(1:500; Abcam). Nuclei were counterstained with Hoechst (33258;
Sigma; 0.1 mg/ml). For H&E images, paraffin sections were
prepared as previously described [48]. Sections were examined
with a Leica DMR microscope and digital images were captured
with a DC500 digital camera and IM50 Image Manager Software
(Leica Microsystems) or confocal images were acquired using an
IX81 Inverted Microscope equipped with Fluoview FV1000-
Spinning Disc Confocal (Olympus) scan head and FV10 ASW 1.7
software (Olympus). Cy3 images were captured as grayscale and
digitally converted to red images with Adobe Photoshop CS2
(Adobe Systems Inc.). In some instances, Hoechst or laminin
images were converted to grayscale.
To examine the temporal dynamics of peripheral blood
infiltration and fusion in the intestine, WBM-transplanted WT
mice were analyzed 1–7 days post-transplantation (n=2–6 for
each time point). GFP and Ki67 expression was surveyed in the
DSI by co-staining with antibodies as described above. H&E
images were captured from paraffin tissues prepared from c-IR
treated mice at the same time points.
Analysis for recombination of the Apc allele
DNA was isolated from 10 mm thick paraffin tissue sections from
Apc
fl/fl mice that had received WBM from a Villin-Cre donor. PCR
for the recombined Apc allele was performed as previously reported
[40]. The resulting bands mark various Apc status: Unrecombi-
ned=314 bp, Recombined=258 bp, Wildtype=226 bp. Controls
were run with the following primers (P3, P4, P5 from [40]):
59GTTCTGTATCATGGAAAGATAGGTGGTC39;5 9CACT-
CAAAACGCTTTTGA GGGTTGATTC39;5 9GAGTACGGG-
GTCTCTGTCTCAGTGAA39. Touchdown from 65uCt o5 5 uC,
followed by 14 cycles at 55uC. Experimental samples were run with
a nested PCR as follows: 1
st PCR reaction: F-59TAACCTGTT-
CTGCAGTATGTTATCATTC39 R-59GAGCACCCAGTACG-
CTTCTAGAG39. Touchdown from 65uCt o5 2 uC, followed by 9
cycles at 52uC; extension time of 4 minutes. 2
nd PCR reaction (P3
and P5 primers from [40]: F-59GTTCTGTATCATGGAAAGA-
TAGGTGGTC39 R-59GAGTACGGGGTCTC TGTCTCAGT-
GAA39. Touchdown from 65uCt o5 5 uC followed by 14 cycles at
55uC.
Analysis of liver and skeletal muscle
WT mice were exposed to a single dose of whole-body c-IR
(9Gy) [11] and sacrificed 1–7 days later. Liver and skeletal muscle
(quadicep, tibialis anterior and soleus muscles) were isolated and
fixed in 4% paraformaldehyde and prepared as a frozen block.
Tissue sections (10 mm) were co-stained for the proliferation
marker Ki67 as described above, along with cell-type specific
antibodies. Skeletal muscle was pretreated to eliminate auto-
fluorescence by incubating tissue in sodium tetraborohydrate
(10 mg/ml; Sigma), followed by subsequent staining for myosin
heavy chain (Anti-myosin MY-32; 1:750; Sigma) using a mouse-
on-mouse detection kit (M.O.M.; Vector Labs) followed by
secondary detection with Anti-Biotin Cy5 Streptavidin (1:200;
Jackson ImmunoResearch). Liver sections were initially stained
with Ki67, imaged, and sequentially stained using rabbit anti-FAH
(1:10,000; a kind gift from Markus Grompe [49]) followed by Cy5
secondary detection. Nuclei were counterstained with Hoechst
dye. Digital images were captured as described above. Ki67-
positive cells were quantified from 7 distinct 20x fields of view
containing approximately 3500 hepatocytes or for skeletal muscle,
4 distinct 40x fields of view containing approximately 500 nuclei.
Inflammation assay
Quantitative reverse transcriptase polymerase chain reaction
(qRT-PCR) was used to measure changes in the mRNA levels of
Interleukin-1b (IL-1b) and Melanin-concentrating hormone re-
ceptor 1 [27] (Mchr1) in isolated epithelial and mesenchymal cell
populations from transplanted mice. Epithelial cell populations
were isolated using a modified Weiser preparation [40,41] as we
previously described [36]. Following epithelial cell isolation,
mesenchymal cells were isolated by scraping the remaining tissue
on a tissue sieve (Bellco Glass, Inc.) to dislodge the mesenchymal
population. Total RNA was purified from each cell population
and cDNA was synthesized as we have previously described [50].
qRT-PCR was performed using a SYBR Green-based assay and a
7900 HT Sequence Detector according to established protocols
[29,42,43]. Each cDNA sample was analyzed in triplicate, along
with triplicate samples of the endogenous reference gene,
Glyceraldehyde-3-phosphate dehydrogenase (Gapdh). Primers
used are listed as follows: Gapdh: F- 59AAATATGACAACT-
CACTCAAGATTGTCA39,R -5 9CCCTTCCACAATGCCAA-
AGT39; Mchr1: F-59GGTAATGGTGTCTGGCACTTTG39,
R-59 GCCATAGCAGTCAGGAT GTAGGT39; IL-1b: F-59CG-
TGCTGTCGGACCCATATG39, R-59GCCCAAGGCCA CA-
GGTATTTT39.
Statistics
Cell fusion was quantified by reporting the total number of
crypt/villus (DSI) or crypt/cuff (colon) units harboring at least one
or more GFP-positive cell(s). A unit is defined as one villus and its
adjacent crypt (DSI) or a single colonic crypt and its adjacent
epithelial cuff (colon). For each animal, tissue sections at least
125 mm apart were quantified and at least 1500 units were
examined. This quantification standard reports the percentage of
units containing at least one fusion event. We do not quantitate on
a per cell basis because this would overestimate the extent of cell
fusion due to proliferative expansion of the initial fusion event.
Statistical significance between experimental populations was
determined using a Student’s two-tailed, paired t-test or unpaired
t-test as determined appropriate for each experimental scenario. P
Intestinal Cell Fusion
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analysis was performed using GraphPad Prism for Windows
(GraphPad Software). All data are presented as the mean6s.e.m.
Supporting Information
Figure S1 GFP-expressing cell type. Wild-type (WT) mice were
transplanted with GFP-expressing whole bone marrow (WBM). (A–
F) Five mm sections from DSI (A–C) and colon (D–F) were stained
with Rabbit anti-GFP antibodies followed by Anti-Rabbit Cy5
secondary antibodies. Images were captured in the FITC channel
(A,D; green) to document endogenous GFP fluorescence, followed
by capturing the same region in the Cy5 channel (B,E; red) to
document the GFP antibody-stained tissue. These images were
overlayed (C,F; yellow). Since the FITC and Cy5 channels are
spectrally distinct, this demonstrates the Rabbit anti-GFP antibody
is accurately representing endogenous GFP expression in the mouse
intestinal blood cell compartment and epithelium. Arrowheads
indicate examples of GFP-positive epithelium. (G–J) GFP-express-
ing epithelium (green) can be identified by co-staining with the
epithelial cell marker E-cadherin (red; arrowheads mark yellow co-
stained cellsinthecrypt;arrowmarksco-stained cellsonthe cuff).(I)
Higher magnification of white boxed region in panels G & H. (J)
Further magnification of red boxed region from panel I. GFP-
positive laminia propria can be observed next to a GFP-positive
epithelial cell co-staining for E-cadherin. (K–O) The GFP-positive
epithelium can be distinguished from the GFP-positive blood cells.
Five micron DSI sections were co-stained for GFP and CD45. (K)
Most CD45-positive cells reside within the lamina propria of the
villus core, however, some lie along the base of the epithelial cells
(arrowheads), known as intra-epithelial lymphocytes (IELs). (L)
GFP-expressing epithelium (red arrowheads) can be distinguished
from GFP-expressing blood cells (white arrowheads) in this co-
stained image. (M–O) GFP-expressing epithelium can be distin-
guished from CD45-positive IELs because while the nuclei of the
IEL are small and sit at the base of the epithelial layer (arrowheads),
the epithelial cells have larger/longer nuclei oriented in a single
layer and the cell extends much further towards the lumen. The
epithelial cells that are GFP-positive can be appreciated (brackets)
when juxtaposed to GFP-negative epithelial regions and are distinct
from IELs (arrowheads). The long columnar shape of the GFP-
positive epithelial cells is distinct from blood cells residing in the
lamina propria or IELs. Dashed white lines indicate epithelial/
mesenchymal border. Bars=25 mm.
Found at: doi:10.1371/journal.pone.0006530.s001 (4.55 MB TIF)
Figure S2 Fluorescence background controls. (A–D) Detection
of endogenous GFP fluorescence from a Y01 GFP mouse DSI (A–
B) and colon (C–D). WT C57B6 mouse DSI (E–F) and colon (G–
H) do not exhibit appreciable levels of autofluorescence in the
FITC channel. (I–L) There is no detectable signal in the FITC
channel from DSI (I–J) or colon (K–L) that has been stained with
Anti-Rabbit Alexa 488 secondary antibody alone. Images in
panels B & C were captured under the same configuration, but at
one-third the exposure time as panels E,G,I,K. Nuclei are stained
with Hoechst dye (A,C,E,G,I,K; blue). Bars=25 mm.
Found at: doi:10.1371/journal.pone.0006530.s002 (1.92 MB TIF)
Figure S3 FISH controls. (A) Five micron cross-section of distal
small intestine from a male GFP mouse was stained for GFP and
developed with DAB (brown). Both GFP-positive (upper black
box) and GFP-negative (lower black box) regions are identified due
to the variegation of the GFP expression in this mouse. Y-
chromosome can be detected in the nuclei in both boxed regions
as magnified in B & C, demonstrating that the Y-chromosome
probe can successfully detect Y-chromosome when the GFP
antibody and detection reagents are present. (D) A crypt from a
female mouse stained with the Y-chromosome probe demonstrat-
ing the lack of staining and the specificity of the probe. Nuclei are
stained with Hoechst dye. Bars=25 mm.
Found at: doi:10.1371/journal.pone.0006530.s003 (3.26 MB TIF)
Figure S4 Defining Fusion. (A–C) Rosa mice transplanted with
GFP-expressing bone marrow were analyzed for fusion in the
epithelium by confocal microscopy. Tissue from the distal small
intestine were co-stained for GFP (green; donor), b-gal, (red;
recipient), laminin (grayscale; laminia propria compartment), and
Hoechst (blue; nuclei). Fusion can be detected in the epithelium
(brackets)bythe co-expressionofGFPand b-gal.Dashed whitelines
indicate epithelial/mesenchymal border and were drawn based on
laminin staining from panel A. (D) A broad view of a typical stretch
of DSI tissue after transplantation. The GFP-expressing epithelium
indicative of fusion is apparent (asterisks). Bars=25 mm.
Found at: doi:10.1371/journal.pone.0006530.s004 (4.64 MB TIF)
Figure S5 Amounts of fusion can be modulated. (A) Wild-type
(WT) mice were transplanted with GFP-expressing whole bone
marrow (WBM). An example of a stretch of tissue from the colon
stained with antibodies against GFP and laminin demonstrated an
appreciable amount of GFP-positive fused epithelium (asterisks). (B)
When IL-10-/- mice were transplanted with GFP-expressing
WBM, the amount of GFP-positive epithelial fusion that could be
quantified increased compared to WT (asterisks), but was decreased
again when the anti-inflammatory 5-ASA was given (C). Left-hand
panels are higher magnifications of boxed regions from the larger
stretches of tissue on the right, demonstrating GFP-positive
epithelium on the colonic cuffs and in the crypts. Dashed white
lines indicate epithelial/mesenchymal border. Bars=25 mm.
Found at: doi:10.1371/journal.pone.0006530.s005 (4.93 MB TIF)
Figure S6 Dextran Sodium Sulfate (DSS) Model of colonic
inflammation. After separation, a subset of parabiotic mice were
administered dextran sodium sulfate (DSS), to induce inflamma-
tion. Wholemount colon from a DSS-treated mouse (B) has major
inflammatory changes compared to a wild type mouse (A). This is
further appreciated by H&E, where the DSS-treated animal has
extensive immune infiltrate (D, arrowheads) compared to the WT
colon cross-section (C). Bars in A & B=1.5 mm. Bars in C &
D=25mm.
Found at: doi:10.1371/journal.pone.0006530.s006 (4.05 MB TIF)
Figure S7 Liver hepatocytes and skeletal muscle have a
proliferative response to lethal irradiation. To examine prolifer-
ation in the liver and skeletal muscle after irradiation-induced
injury, wild type (WT) mice were administered a single lethal dose
of whole-body gamma-IR (9Gy). Liver and skeletal muscle
(quadricep, tibialis anterior and soleus muscles) were isolated 7
days post-irradiation. (A–D) Liver and skeletal muscle sections
from lethally irradiated mice were stained with the proliferative
marker Ki67 (green), either FAH (liver; red) or myosin (muscle;
red) and Hoechst dye (blue). White arrowheads indicate Ki67-
positive nuclei. Boxed regions in A & B are magnified in C & D.
(G,H) Quantification of percentage Ki67-positive nuclei revealed
that lethally irradiated mice harbored a marked proliferative
response in the liver and skeletal muscle when compared to
unirradiated control animals.
Found at: doi:10.1371/journal.pone.0006530.s007 (2.64 MB TIF)
Table S1 Inflammatory Status. qRT-PCR was carried out for
Interleukin-1b (IL-1b and Melanin-concentrating hormone recep-
tor 1 (Mchr1) on various experimental samples to determine
changes in inflammatory status. These genes have been demon-
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human and mouse samples. mRNA was isolated from either whole
intestine, mesenchyme, or epithelium and cDNA transcribed.
Each sample was normalized to Gapdh and compared to its
appropriate baseline control. The IL-10-/- samples exhibited
decreases when treated with anti-inflammatory drugs, while the
AhCre+;Apc-/- proliferative model samples showed no change in
inflammatory status when compared to mock-injected controls.
Found at: doi:10.1371/journal.pone.0006530.s008 (0.06 MB
PDF)
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